Published Market Research Insights

Payal Rabde is a Healthcare Market Research Analyst specializing in the ophthalmic diagnostic devices market. She tracks the growing ophthalmic diseases, expanding diagnostic devices, and increasing AI applications. Her research provides in-depth market intelligence, competitive analysis, and strategic insights to support AI-enabled ophthalmic ...

Based on market forecasts, the non-invasive prenatal testing sector will expand from USD 6.45 billion in 2024 to USD 18.94 billion by 2034, experiencing a CAGR of 11.65%. The non-invasive prenatal testing market is growing due to the increasing demand for safer, earlier, and accurate detection of fetal genetic disorders. North America is dominating...

According to forecasts, the global intranasal drug delivery devices market will grow from USD 1.91 billion in 2025 to USD 4.98 billion by 2035, with an expected CAGR of 10.04%. The intranasal drug delivery devices market is growing as it provides rapid drug onset, avoids first-pass metabolism, and is non-invasive to maximise patient comfort and com...

According to market projection, the gene-editing therapeutics market is entering a rapid expansion phase, rising from USD 2.47 billion in 2026 to USD 18.15 billion by 2035 at a 24.80% CAGR. Research identifies CRISPR/Cas, ex-vivo edited cell therapies, and genetic and rare disease applications as the market's leading segments, while base/prime edit...

The tumor fluid biopsy market is growing because this technique has drastically transformed the sector of clinical oncology, offering ease in tumor sampling, continuous monitoring by repeated sampling, inventing targeted therapeutic regimens, and screening for therapeutic resistance. North America is dominated due to advanced healthcare infrastru...

Projections indicate that, operating room equipment industry is projected to rise from USD 48.65 billion in 2024 to USD 103.49 billion by 2034, reflecting a CAGR of 7.84% over the next decade.The operating room equipment market is growing due to its pivotal role in facilitating surgical procedures and ensuring optimal outcomes. North America is d...

Market insights predict, the metagenomic sequencing industry is expected to grow from USD 2.86 billion in 2026 to USD 8.62 billion by 2035, driven by a CAGR of 13.04%. The rising prevalence of genetic and infectious disorders and the growing demand for biologics bolster market growth. North America led the global market owing to the availability of...

According to Payal Rabde, who specializes in analyzing metabolites and metabolic processes to understand diseases, discover biomarkers, and support drug development and personalized medicine, with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the metabolomics market. The...

According to Payal Rabde, who specializes in managing, storing, processing, analyzing, and sharing medical images to support accurate diagnosis and efficient patient care, with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the medical imaging informatics market. The glob...

According to Payal Rabde, who specializes in detecting diseases and biomarkers using antibodies, antigens, and immune-based diagnostic techniques, with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the immunodiagnostics market. The global immunodiagnostics market size wa...